These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4994370)

  • 1. [New antitubercular drugs and their clinical use].
    Pregowski W
    Pol Tyg Lek; 1971 Feb; 26(7):244-7. PubMed ID: 4994370
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives.
    Candéa AL; Ferreira Mde L; Pais KC; Cardoso LN; Kaiser CR; Henriques Md; Lourenço MC; Bezerra FA; de Souza MV
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6272-4. PubMed ID: 19819134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with new tuberculostatics in the treatment of urogenital tuberculosis (capreomycin, ethambutol, rifampicin)].
    May P; König K
    Z Urol Nephrol; 1969; 62(9):657-62. PubMed ID: 5408556
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new antitubercular agent: rifampicin].
    Favez G
    Schweiz Rundsch Med Prax; 1970 Feb; 59(8):296-7. PubMed ID: 4996719
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN; Sengupta SR
    Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
    Echeverría MJ; Ayarza R; Jiménez MS; López de Goicoechea MJ; Berdonces P; Ibarretxebea AB
    Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance to antitubercular drugs in patients with tuberculosis registered in the antituberculosis clinics in Poland 1966-1980].
    Szczuka I
    Pneumonol Pol; 1982 Oct; 50(10):497-501. PubMed ID: 6820494
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C; Andreis G
    G Ital Chemioter; 1966; 13(1):109-27. PubMed ID: 4967318
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modern chemotherapy of tuberculosis].
    Unholtz K
    Munch Med Wochenschr; 1970 May; 112(21):1003-11. PubMed ID: 5467739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental tuberculosis in mice, a model for the study of antitubercular chemotherapy].
    Rist N
    Arch Roum Pathol Exp Microbiol; 1971 Jun; 30(2):295-6. PubMed ID: 5004388
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comments on the current state of experimental chemotherapy of tuberculosis].
    Urbancík R; Markovic J
    Z Tuberk Erkr Thoraxorg; 1967; 126(3):169-73. PubMed ID: 4971152
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.